dendritic cells - transfected with htert-, survivin- and tumor cell derived mrna + ex vivo t cell expansion and reinfusion
Cell therapyexperimental
Clinical trial activity
1 trials · 2 clinical orgs · 0 marketing orgs
Phase 1
1
Phase 2
1
Phase 3
0
Phase 4
0
Earliest trial started Aug 1, 2009 (NCT00961844)
Timeline
2000s
- Jan 1, 2009
Earliest Phase 1 Sponsor(trial)
Indications
Studied for
Mechanism of action
- Tumor antigensImmunity, active
immunity, active - tumor antigens
Chemistry & pharmacology
Oral
No
Parenteral
No
Topical
No
Also known as
- dendritic cells - transfected with htert-, survivin- and tumor cell derived mrna + ex vivo t cell expansion and reinfusion
Clinical trials
| NCT ID | Phase | Start date | Sponsor(s) |
|---|---|---|---|
| NCT00961844 | Phase 1/Phase 2 (Phase 2) | Aug 1, 2009 | Osaka University, University of Oslo |
Showing 1 of 1 trials
Page 1 / 1
Organizations
Research & Development (2)
| Organization | Org type | Trials | As lead sponsor | Phases | Earliest year |
|---|---|---|---|---|---|
| Osaka University | Academic/Hospital | 1 | 1 | 1 | 2009 |
| University of Oslo | Academic/Hospital | 1 | 0 | 1 | 2009 |
2 organizations
Page 1 / 1